Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

926

1

CFSB Bancorp, Inc. /MA/ CFSB Bancorp Reports Net Loss of $6,000 in Q3 2024, Down from Net Income of $123,000 in Q3 2023

Via official filing (AI summary) | 9 days ago | 0 comments

927

1

EMPIRE PETROLEUM CORP Empire Petroleum Corporation Reports Revenue Growth, Increased Losses, and Liquidity Challenges in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

928

1

Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals Reports Improved Net Loss, Reduced Operating Expenses in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

929

1

SRM Entertainment, Inc. SRM Entertainment Reports Mixed Financial Results, Net Loss, and Strategic Acquisitions

Via official filing (AI summary) | 9 days ago | 0 comments

930

1

Pasithea Therapeutics Corp. Pasithea Therapeutics Reports Mixed Financial Results, Decrease in Cash Reserves, and Strategic Developments

Via official filing (AI summary) | 9 days ago | 0 comments

931

1

5E Advanced Materials, Inc. 5E Advanced Materials Reports Net Loss of $12.9M, Cash Position Improves Amid Operational Challenges

Via official filing (AI summary) | 9 days ago | 0 comments

932

1

4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics Reports Significant Financial Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

933

1

Viracta Therapeutics, Inc. Viracta Therapeutics Reports Financial Developments, Seeks Additional Funding Amid Ongoing Net Losses

Via official filing (AI summary) | 9 days ago | 0 comments

934

1

Roadzen Inc. Roadzen Inc. Reports 23% Revenue Decline, Significant Increase in Costs and Losses in Latest Quarter

Via official filing (AI summary) | 9 days ago | 0 comments

935

1

Provident Bancorp, Inc. /MD/ Provident Bancorp Reports 71% Decline in Net Income, Strategic Shifts in Lending Practices

Via official filing (AI summary) | 9 days ago | 0 comments

936

1

QUICKLOGIC Corp QuickLogic Reports 36% Revenue Decline in Q3, Net Loss of $2.1M, Amid Increased Investment in Product Development

Via official filing (AI summary) | 9 days ago | 0 comments

937

1

Ashford Inc. Ashford Inc. Reports Mixed Q3 2024 Results with 5.5% Revenue Growth and Net Loss

Via official filing (AI summary) | 9 days ago | 0 comments

938

1

Kyverna Therapeutics, Inc. Kyverna Therapeutics Reports Significant Financial Developments, Including Increased Cash Reserves and Operating Expenses

Via official filing (AI summary) | 9 days ago | 0 comments

939

1

TWFG, Inc. TWFG, Inc. Reports 14.5% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

940

1

Vaxart, Inc. Vaxart Reports Revenue Growth and Improved Operating Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

941

1

DiaMedica Therapeutics Inc. DiaMedica Therapeutics Reports Decreased Assets, Increased R&D Expenses, and Operating Losses in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

942

1

NICHOLAS FINANCIAL INC Old Market Capital Corporation Reports Significant Revenue Growth and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | 9 days ago | 0 comments

943

1

Mobile Infrastructure Corp Mobile Infrastructure Corporation Reports 21% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

944

1

electroCore, Inc. electroCore Reports 45% Revenue Growth, Improved Operational Efficiency in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

945

1

Cardio Diagnostics Holdings, Inc. Cardio Diagnostics Reports Mixed Q3 Results, Revenue Growth and Improved Losses Amid Ongoing Liquidity Challenges

Via official filing (AI summary) | 9 days ago | 0 comments

946

1

CADIZ INC Cadiz Inc. Reports Significant Revenue Growth, Improved Operating Results in Latest 10-Q Filing

Via official filing (AI summary) | 9 days ago | 0 comments

947

1

SONIM TECHNOLOGIES INC Sonim Technologies Reports Significant Revenue and Profit Declines in Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 9 days ago | 0 comments

948

1

BT Brands, Inc. BT Brands Reports 5.2% Revenue Growth, Operating Loss Amid Rising Costs and Challenges

Via official filing (AI summary) | 9 days ago | 0 comments

949

1

Goodness Growth Holdings, Inc. Vireo Growth Reports 2% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

950

1

Adaptimmune Therapeutics PLC Adaptimmune Reports Significant Revenue Growth and Improved Financials in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments